Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol. 2004; 6(6): 411-6.

Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Mol Imaging Biol. 2004; 6(1): 47-54.

Obrzut SL, Halpern BS, Monchamp T, Grabski K, Watts WJ, Czernin J The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor. Mol Imaging Biol. 2004; 6(3): 126-30.

Czernin J, Weber W Translational molecular imaging. Mol Imaging Biol. 2004; 6(4): 181-2.

Czernin J, Waldherr C Cigarette smoking and coronary blood flow.. Progress in cardiovascular diseases. . 2003; 45(5): 395-404.

Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Mol Imaging Biol. 2003; 5(4): 232-9.

Pio BS, Byrne FR, Aranda R, Boulay G, Spicher K, Song MH, Birnbaumer L, Phelps ME, Czernin J, Silverman DH. Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells.. Mol Imaging Biol. 2003; 5(4):: 271-7. .

Schiepers C, Filmont JE, Czernin J PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging. 2003; 30 Suppl 1: S82-8.

Silverman DH, Truong CT, Kim SK, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET.. Mol Genet Metab. 2003; 80(3):: 350-5. .

Schoder H, Brown K, Said J, Czernin J A Patient with Primary Cardiac Lymphoma.. J Mol Imag Biol. 2002; 4(4):: 274-275.

Silverman DH, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, Phelps ME. Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment.. Mol Imaging Biol. 2002; 4(4):: 283-93. .

Czernin J Clinical applications of FDG-PET in oncology.. Acta medica Austriaca. . 2002; 29(5): 162-70.

Wong C, Silverman DH, Seltzer M, Schiepers C, Arianejad M, Gambhir SS, Phelps ME, Rao J, Valk P, Czernin J The Impact of 2-deoxy-2[F-18]fluoro-D-glucose (FDG) Whole Body Positron Emission Tomography (PET) for Managing Patients with Melanoma: The Referring Physician?s Perspective.. Mol Imag Biol. 2002; 4(2): : 185-190. .

Seltzer MA, Yap C, Silverman DH, Meta J, Schiepers C, Phelps ME, Sayre J, Ariannejad M, Gambhir SS, Rao J, Valk PE, Czernin J The Impact of Positron Emission Tomography on the Management of Patients with Lung Cancer: The Referring Physician?s Perspective.. J Nucl Med. 2002; 43(6): : 752-56..

Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J The Usefulness of F-18 Deoxy-Glucose Whole Body Positron Emission Tomography (PET) for Re-Staging of Renal Cell Cancer.. 2002; 57(1): : 56-62..

Kwan A, Seltzer M, Czernin J, Chou MJ, Kao CH Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects.. Anticancer research. . 2001; 21(1B): 701-6.

Schoder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J Effect of the whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.. J Nucl Med 2001; 42(8): : 1139-43..

Madsen MM, Bottcher M, Toftegaard Nielsen T, Czernin J . Altered regulation of the myocardial microcirculation in young smokers.. Cardiology. 2000; 94(2): : 91-8..

Allen-Auerbach M, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, Silverman D, Phelps ME, Schelbert HR, Czernin J. Prevalence of myocardial viability as detected by PET in patients with ischemic cardiomyopathy.. Circulation 1999; 99(22):: 2921-26.

Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2005; 46(1): 114-20.

Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2004; 45(5): 797-801.

Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2004; 45(2): 290-3.

Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2003; 44(8): 1238-42.

Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation.. Chest. . 2003; 124(2): 608-13.

Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. European journal of nuclear medicine and molecular imaging. . 2002; 29(9): 1166-73.

Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2002; 43(3): 325-9.

Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2002; 43(2): 253-66.

Czernin J FDG-PET in breast cancer: a different view of its clinical usefulness.. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging. . 2002; 4(1): 35-45.

Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.. JAMA : the journal of the American Medical Association. . 2001; 286(17): 2120-7.

Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2001; 42(9): 1334-7.

Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME A tabulated summary of the FDG PET literature.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2001; 42(5 Suppl): 1S-93S.

Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2001; 42(4): 586-90.

Park KC, Schwimmer J, Shepherd JE, Phelps ME, Czernin JR, Schiepers C, Gambhir SS Decision analysis for the cost-effective management of recurrent colorectal cancer.. Annals of surgery. . 2001; 233(3): 310-9.

Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. . 2000; 41(7): 1177-89.

Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, Phelps ME, Czernin J, Gambhir SS A review of the literature for whole-body FDG PET in the management of patients with melanoma.. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR). . 2000; 44(2): 153-67.